Tafolecimab
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Tafolecimab, covering 2024-05-20 to 2025-07-11. Get the full timeline:
Most recent: Clinical Trial Update: Sintilimab Combined With Tafolecimab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer [Phase 2]